SynthesisEndocrine2019

GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials.

Chuqing Cao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.